(Q33946915)

30 July 2017

1 reference

title

Pharmacodynamics of human immunodeficiency virus type 1 protease inhibitors (English)

1 reference

30 July 2017

1 reference

E P Acosta

1

1 reference

30 July 2017

T N Kakuda

2

1 reference

30 July 2017

R C Brundage

3

1 reference

30 July 2017

P L Anderson

4

1 reference

30 July 2017

C V Fletcher

5

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

Clinical Infectious Diseases

30 July 2017

1 reference

30 July 2017

30 Suppl 2

1 reference

30 July 2017

S151-9

1 reference

Intracellular phosphorylation of zidovudine (ZDV) and other nucleoside reverse transcriptase inhibitors (RTI) used for human immunodeficiency virus (HIV) infection

30 July 2017

1 reference

A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group

21 January 2018

1 reference

A preliminary evaluation of nelfinavir mesylate, an inhibitor of human immunodeficiency virus (HIV)-1 protease, to treat HIV infection

21 January 2018

1 reference

Activity of a ritonavir plus saquinavir-containing regimen in patients with virologic evidence of indinavir or ritonavir failure

21 January 2018

1 reference

Diurnal variation of alpha 1-acid glycoprotein concentration in normal volunteers.

21 January 2018

1 reference

In vitro effect of alpha1-acid glycoprotein on the anti-human immunodeficiency virus (HIV) activity of the protease inhibitor CGP 61755: a comparative study with other relevant HIV protease inhibitors

21 January 2018

1 reference

The effect of high-dose saquinavir on viral load and CD4+ T-cell counts in HIV-infected patients.

21 January 2018

1 reference

Ordered accumulation of mutations in HIV protease confers resistance to ritonavir

21 January 2018

1 reference

A pilot study of nevirapine, indinavir, and lamivudine among patients with advanced human immunodeficiency virus disease who have had failure of combination nucleoside therapy

21 January 2018

1 reference

Antiviral effect and pharmacokinetic interaction between nevirapine and indinavir in persons infected with human immunodeficiency virus type 1.

21 January 2018

1 reference

Indinavir concentrations and antiviral effect

21 January 2018

1 reference

Urological complaints in relation to indinavir plasma concentrations in HIV-infected patients

21 January 2018

1 reference

The effect of plasma drug concentrations on HIV-1 clearance rate during quadruple drug therapy.

21 January 2018

1 reference

Therapeutic drug monitoring

21 January 2018

1 reference

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/313852

1 reference

30 July 2017

1 reference